Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Prosensa Hldgs B V Shs Usd, Dicerna Pharmaceuticals, Supernus Pharmaceuticals, Portola Pharmaceuticals, AMRN. These five stock positions account for 81.16% of Abingworth's total stock portfolio.
- Added to shares of these 3 stocks: Prosensa Hldgs B V Shs Usd (+$34.86M), Dicerna Pharmaceuticals (+$33.31M), Regulus Therapeutics.
- Started 3 new stock positions in Dicerna Pharmaceuticals, Regulus Therapeutics, Prosensa Hldgs B V Shs Usd.
- Reduced shares in these 4 stocks: Anthera Pharmaceuticals (-$10.27M), (-$9.69M), ZLCS, Portola Pharmaceuticals.
- Sold out of its positions in ALNY.
- As of March 31, 2014, Abingworth has $181.25M in assets under management (AUM). Assets under management grew from a total value of $129.97M to $181.25M.
- Independent of market fluctuations, Abingworth was a net buyer by $50.68M worth of stocks in the most recent quarter.
Abingworth portfolio companies for March 2014 quarter
|Ticker||Name||Portfolio Weight||Change||Share Count||Price||Last Trade|
|Prosensa Hldgs B V Shs Usd||19.23||NEW||6213924||5.61||0.00|
|Gw Pharmaceuticals Plc ads||3.35||102200||59.36||0.00|
Past 13F-HR SEC Filings for Abingworth
- Abingworth 2013 Q2 - filed Aug. 14, 2013
- Abingworth 2013 Q1 - filed May 15, 2013
- Abingworth 2012 Q4 - filed Feb. 13, 2013
- Abingworth 2012 Q3 - filed Nov. 7, 2012
- Abingworth 2012 Q1 - filed May 14, 2012
- Abingworth 2011 Q4 - filed Feb. 7, 2012
- Abingworth 2011 Q3 - filed Nov. 14, 2011
- Abingworth 2011 Q1 - filed May 13, 2011
- Abingworth 2010 Q4 - filed Feb. 14, 2011